Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CVRx, Inc. (CVRX : NSDQ)

• Company Description    CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN. Number of Employees: 206

• Price / Volume Information    Yesterday's Closing Price: $7.87 Daily Weekly Monthly 20 Day Moving Average: 170,679 shares Shares Outstanding: 26.15 (millions) Market Capitalization: $205.82 (millions) Beta: 1.26 52 Week High: $18.55 52 Week Low: $4.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 8.70% 6.79% 12 Week 34.99% 22.62% Year To Date -37.88% -41.93%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9201 WEST BROADWAY AVENUE SUITE 650 - MINNEAPOLIS,MN 55445 USA ph: 763-416-2840 fax: 763-416-2841 ir@cvrx.com http://www.cvrx.com

• General Corporate Information    Officers Kevin Hykes - Chief Executive Officer and President Jared Oasheim - Chief Financial Officer Kevin Ballinger - Director Mitch Hill - Director Mudit Jain - Director Peer Information CVRx, Inc. (ABMD) CVRx, Inc. (DMDS) CVRx, Inc. (CPWY.) CVRx, Inc. (EQUR) CVRx, Inc. (ECIA) CVRx, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 126638105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/04/25 Share - Related Items Shares Outstanding: 26.15 Most Recent Split Date: (:1) Beta: 1.26 Market Capitalization: $205.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.50 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.00 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.55 Price/Cash Flow: - Price / Sales: 3.77 EPS Growth vs. Year Ago Period: 12.31% vs. Previous Quarter: -7.55% Sales Growth vs. Year Ago Period: 15.09% vs. Previous Quarter: 10.05% ROE 06/30/25 - -79.31 03/31/25 - -79.04 12/31/24 - -93.06 ROA 06/30/25 - -40.96 03/31/25 - -42.37 12/31/24 - -51.78 Current Ratio 06/30/25 - 11.99 03/31/25 - 14.82 12/31/24 - 12.06 Quick Ratio 06/30/25 - 10.78 03/31/25 - 13.45 12/31/24 - 10.94 Operating Margin 06/30/25 - -95.61 03/31/25 - -97.49 12/31/24 - -116.91 Net Margin 06/30/25 - -95.61 03/31/25 - -97.49 12/31/24 - -116.91 Pre-Tax Margin 06/30/25 - -95.67 03/31/25 - -97.47 12/31/24 - -116.80 Book Value 06/30/25 - 2.22 03/31/25 - 2.66 12/31/24 - 2.93 Inventory Turnover 06/30/25 - 0.76 03/31/25 - 0.75 12/31/24 - 0.72 Debt-to-Equity 06/30/25 - 0.85 03/31/25 - 0.71 12/31/24 - 0.69 Debt-to-Capital 06/30/25 - 46.02 03/31/25 - 41.56 12/31/24 - 40.95

Powered by Zacks Investment Research ©